CETRORELIX 0.25 MG

CETRORELIX 2.5 MG

Cetrorelix 2.5 MG is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) antagonists. It is primarily used in assisted reproductive technology (ART) to prevent premature ovulation in women undergoing controlled ovarian stimulation (COS) for in vitro fertilization (IVF). Cetrorelix works by blocking the effects of GnRH in the body, which prevents the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) that trigger ovulation. By delaying ovulation, Cetrorelix can help increase the chances of successful IVF outcomes. Cetrorelix is typically administered as a subcutaneous injection, and the dosage and duration of treatment will depend on the individual’s response to the medication and the specific IVF protocol being used. It is important to follow the dosing instructions provided by a healthcare professional when taking Cetrorelix 2.5 MG, and to be aware of the potential side effects associated with this medication, such as injection site reactions, headaches, and nausea.

Cetrorelix 2.5 MG is typically administered as a subcutaneous injection, and the dosage and duration of treatment will depend on the specific fertility protocol being followed and the individual’s response to the medication. It is important to follow the dosing instructions provided by a healthcare professional when taking Cetrorelix 2.5 MG, and to be aware of the potential side effects associated with this medication, such as headache, nausea, and injection site reactions.